CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 4/A Open-market buy Director bought 7,100 shares at an average $1.18 ($8,367)
- 4 Open-market buy Director bought 7,100 shares at an average $1.39 ($9,868)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Agreement ended
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 5,000 shares at $1.66 ($8,280)
- 4 Open-market buy Director bought 1,648 shares at $1.68 ($2,769)
- 4 Open-market buy Director bought 5,000 shares at $1.73 ($8,650)
- 4 Open-market buy Director bought 5,372 shares at an average $1.85 ($9,946)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 3,128 shares at $1.60 ($4,993)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $1.61 ($32,172)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
Page 11 of 17 · 328 filings